Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lidocaine + sodium bicarbonate is a combination used primarily to provide local anesthesia with reduced pain on injection. Lidocaine is an amide-type local anesthetic that works by stabilizing neuronal membranes and inhibiting the ionic fluxes required for the initiation and conduction of nerve impulses, specifically by blocking voltage-gated sodium channels. Sodium bicarbonate acts as a buffering agent; when added to lidocaine, it raises the pH of the solution, which increases the proportion of un-ionized (active) form of lidocaine available to penetrate nerve membranes. This can hasten onset and reduce pain during infiltration. The combination is commonly used in clinical practice for procedures requiring local anesthesia, especially where minimizing injection discomfort is desired[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lidocaine + sodium bicarbonate.